Loading…
BioAge Labs, Inc. is projected to rise to $10.04 by 2027, a +11% move from its current price of $9.04. BIOA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $8.43 | $9.04 | $9.70 | +0.02% |
| Aug 4 | $8.19 | $9.04 | $9.99 | +0.03% |
| Aug 5 | $8.01 | $9.04 | $10.21 | +0.05% |
| Aug 6 | $7.86 | $9.05 | $10.41 | +0.06% |
| Aug 7 | $7.73 | $9.05 | $10.58 | +0.08% |
| Aug 8 | $7.62 | $9.05 | $10.75 | +0.09% |
| Aug 9 | $7.52 | $9.05 | $10.90 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.52 | $9.05 | $10.90 | +0.11% |
| Week 2 | $6.97 | $9.06 | $11.78 | +0.21% |
| Week 3 | $6.57 | $9.07 | $12.51 | +0.32% |
| Week 4 | $6.26 | $9.08 | $13.16 | +0.42% |
| Week 5 | $6.00 | $9.09 | $13.77 | +0.53% |
| Week 6 | $5.77 | $9.10 | $14.34 | +0.64% |
| Week 7 | $5.57 | $9.11 | $14.89 | +0.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company focused on metabolic diseases. Its technology platform and differentiated human datasets allow researchers to identify targets based on insights into molecular changes that drive aging.
Its lead product candidate is BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor in Phase 1 clinical trial for the treatment of atherosclerotic cardiovascular disease as well as for diabetic macular edema and geographic atrophy. The company also develops APJ agonists for obesity, including programs for both oral and parenteral administration. It has a collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets related to aging.
BioAge Labs was incorporated in 2015 and is headquartered in Emeryville, California.
BioAge Labs, Inc. (BIOA) trades at current price of $24.85 and has a market capitalization of $1.1B. It is ranked 2317 in the market by size. The price outlook from the provided forecast shows path-dependent upside, with the 2026 average price at $24.85 and a trajectory rising to $66.07 by 2030 and $458.86 by 2050, while the 2026 min and max sit at $12.62 and $34.00 respectively.
A major floor 0.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 177.7% above — a clean break opens room to run.
A major ceiling 236.9% above — clearing it would confirm fresh momentum.
Key BIOA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BIOA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.78 | Sell | $18.27 | Sell |
| MA 10 | $20.95 | Sell | $20.14 | Sell |
| MA 20 | $22.19 | Sell | $21.17 | Sell |
| MA 50 | $20.35 | Sell | $20.72 | Sell |
| MA 100 | $19.12 | Sell | $19.37 | Sell |
| MA 200 | $16.52 | Sell | $16.83 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 24.78 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -543.73 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.97 | Sell |
| ROC (12) | -60.18 | Sell |
| Bollinger %B (20,2) | -0.52 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | -2.42 | Sell |
| Ultimate (7,14,28) | 22.45 | Buy |
| Momentum (10) | -13.77 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 19.33 | Sell |
| ADX (14) | 18.08 | Neutral |
| ATR (14) | 1.86 | Info |
The 30-day technical picture is described as BULLISH, with RSI14 at 60. The SMA50 sits at $20.50 and the SMA200 at $16.51. Near-term support is identified at $19.99 and resistance at $25.10. The 30-day price range spans from $19.27 to $32.04, indicating a defined window for near-term movement.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.04 | $9.04 | $12.50 | 0% | Neutral | |
| $7.31 | $10.04 | $14.89 | +11% | Neutral | |
| $7.11 | $10.37 | $16.42 | +15% | Neutral | |
| $10.83 | $16.66 | $27.70 | +84% | Bullish | |
| $13.66 | $22.04 | $38.17 | +144% | Bullish | |
| $13.01 | $21.94 | $39.34 | +143% | Bullish | |
| $15.21 | $26.75 | $49.48 | +196% | Bullish | |
| $13.93 | $25.53 | $48.53 | +182% | Bullish | |
| $12.99 | $24.77 | $48.28 | +174% | Bullish | |
| $19.13 | $37.89 | $75.59 | +319% | Bullish | |
| $23.02 | $51.15 | $112.17 | +466% | Bullish | |
| $56.86 | $126.36 | $290.62 | +13.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $9.04 | $9.04 | $11.96 | +0.00% |
| September 2026 | $8.00 | $9.73 | $12.36 | +7.64% |
| October 2026 | $7.43 | $9.17 | $11.87 | -5.81% |
| November 2026 | $7.34 | $9.16 | $12.06 | -0.02% |
| December 2026 | $7.43 | $9.36 | $12.50 | +2.19% |
Click any year to see its month-by-month BIOA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, BIOA could reach as high as $12.50, with a base case around $9.04 and support toward $9.04 — roughly 0% from $9.04. Price action looks broadly range-bound.
Expect BIOA to range from $7.31 to $14.89 through 2027. The $10.04 average target implies a +11% move from current prices. That is up +11% on the projected 2026 average. A consolidation phase looks the most probable path here.
The BIOA price prediction for 2028 points to an average of $10.37 (low $7.11, high $16.42) — a potential gain of +15% on today's $9.04. Price action looks broadly range-bound.
In 2029, BIOA is projected to trade between $10.83 and $27.70, averaging $16.66 — a potential gain of +84% from today's $9.04. That is up +61% on the projected 2028 average. Buyers look set to stay in control over this stretch.
BioAge Labs, Inc.'s 2030 outlook centres on $22.04, within a $13.66 to $38.17 range. That is up +32% on the projected 2029 average. That marks a +144% change versus current levels. Momentum favours further upside here.
By 2031, BIOA could reach as high as $39.34, with a base case around $21.94 and support toward $13.01 — roughly +143% from $9.04. Buyers look set to stay in control over this stretch.
Expect BIOA to range from $15.21 to $49.48 through 2032. The $26.75 average target implies a +196% move from current prices. That is up +22% on the projected 2031 average. Momentum favours further upside here.
The BIOA price prediction for 2033 points to an average of $25.53 (low $13.93, high $48.53) — a potential gain of +182% on today's $9.04. Buyers look set to stay in control over this stretch.
In 2034, BIOA is projected to trade between $12.99 and $48.28, averaging $24.77 — a potential gain of +174% from today's $9.04. That is -3% versus the projected 2033 average. Momentum favours further upside here.
BioAge Labs, Inc.'s 2035 outlook centres on $37.89, within a $19.13 to $75.59 range. That is up +53% on the projected 2034 average. That marks a +319% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, BIOA could reach as high as $112.17, with a base case around $51.15 and support toward $23.02 — roughly +466% from $9.04. Momentum favours further upside here.
Expect BIOA to range from $56.86 to $290.62 through 2050. The $126.36 average target implies a +13.0x move from current prices. That is up +147% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in BIOA today (≈ 110.619469 BIOA) could be worth
$13,977.62
+$12,977.62 (+1298%) by 2050 · US Dollar
Based on the average projected BIOA price of $126.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BIOAwould be worth at today's price.
$1,000 invested in BIOA on Jul 31, 2025 (≈ 227.272722 BIOA) would be worth
$2,054.55
+$1,054.55 (+105.5%) today · 2.05× · US Dollar
Based on a BIOA entry price of $4.4 vs. today's $9.04.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.77 | $415.25 | -58.5% |
| 1 month ago | $24.26 | $372.63 | -62.7% |
| 3 months ago | $16.79 | $538.42 | -46.2% |
| 6 months ago | $20.1 | $449.75 | -55.0% |
| 1 year ago | $4.4 | $2,054.55 | +105.5% |
| All time (1.8y) ago | $18.31 | $493.72 | -50.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BIOA forecast.
Our base-case forecast reaches $18.00 around 2030.
Implied market cap at $18.00: $800.15M
Over the multi-year horizon, the forecast shows bullish sentiment continuing into 2027 and beyond. The 2027 average price is $30.30, rising to $66.07 by 2030 and continuing to $458.86 by 2050, with corresponding ROIs of 21.9, 165.9, and 1746.5 respectively. Key milestones include 2030 with min $45.54, max $103.96 and 2040 with min $105.45, max $369.99, followed by 2050 with min $206.49, max $978.05.
The long-run outlook signals substantial upside potential but remains subject to uncertainty and is not a guarantee of future results.
Tap a question to reveal the answer.
2030 forecast shows min $45.54, avg $66.07, max $103.96, with ROI 165.9 and sentiment BULLISH.
Forecasts indicate bullish sentiment from 2027 onward, with rising average prices (2027 avg $30.30; 2028 avg $34.96; 2029 avg $52.70) and progressively higher ROIs, while 2026 is neutral (avg $24.85; ROI 0, sentiment NEUTRAL).
Yes. The 2030 max forecast is $103.96, with the 2030 average at $66.07, indicating a path to crossing $100 under the forecast.
2026 min $12.62, avg $24.85, max $34.00; ROI 0; sentiment NEUTRAL.
2050 min $206.49, avg $458.86, max $978.05; ROI 1746.5; sentiment BULLISH.
BioAge Labs, Inc. Community Discussion
0Share your BioAge Labs, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.